Latest Articles
-
Five for Friday June 19: Celebrating Success in Advancing Medication Use Quality
Join me as I moderate a July 9 PQA Quality Forum Webinar on integrating pharmacy into AI innovation and governance. Our speakers will be PQA Board Chair Jeff Rochon, who is Executive Director of the Pharmacy Health Information Technology Collaborative, and a representative from the Coalition for Health AI. The PQA Quality Forum Webinar is a recurring series on quality in medication […] -
Refocusing Quality Measures Through the Patient Lens: My Experience at the 2026 PQA Annual Meeting
This blog is one in a series featuring the perspectives of patients, caregivers and patient advocates. PQA supports person-centered care and is committed to engaging individuals and communities as partners in its work to improve safe, effective and appropriate medication use and address issues that impact a person’s ability to access and use medications. Wenora Johnson is a three-time cancer survivor, patient and research advocate, and a […] -
Stay Connected to PQA News
PQA News serves as a central hub for PQA announcements, organizational updates and thought leadership. Designed as part of PQA’s enhanced digital experience, PQA news makes it easier than ever to access timely information and discover content relevant to your interests. A Centralized Source for PQA Updates Whether you are looking for the latest PQA […] -
PQA’s quality roadmap: Micah Cost on the next era of medication quality measurement
Quality measurement is being rebuilt, and PQA is holding the pen. In his RISE Product & Pharmacy Strategy Summit keynote, Micah Cost, CEO of the Pharmacy Quality Alliance, told Medicare leaders the next five years will set the course for the next twenty. -
IRA Cap on Out-of-Pocket Costs for Insulin Associated with Increased Persistence to Basal Insulin in Medicare Advantage Population
Analysis by PQA and Inovalon Shows a Statistically Significant Improvement in Basal Insulin Persistence Overall and Across Numerous Subpopulations in 2023 Alexandria, Va. (June 9, 2026) – The Inflation Reduction Act (IRA) provisions to limit out-of-pocket insulin costs for Medicare beneficiaries was associated with a statistically significant increase in persistence to basal insulin in the […] -
Five for Friday June 5: Celebrating Success in Advancing Medication Use Quality
What can and should we measure when it comes to patient care, experience, and outcomes? What matters most to patients and those who care for them? PQA is facilitating conversations to identify and elevate what patients, caregivers, and patient advocates might value and prioritize for future measurement. My latest article in Drug Topics explores the opportunity to […] -
PQA at 20: Reflecting on Two Decades of Impact
For 20 years, PQA has brought together diverse stakeholders with a shared commitment to improving the quality of medication use and advancing health outcomes. When PQA was established in 2006, health care was beginning to shift toward greater accountability and value. As PQA Chief Executive Officer Micah Cost reflects, “When PQA was formed, the idea was that we were building a value-based construct.” That vision laid the foundation for an organization dedicated to […] -
Quality Professionals and Industry Leaders Gather at the 2026 PQA Annual Meeting
PQA members and health care quality professionals gathered in Baltimore, Md., May 12-14, for the 2026 PQA Annual Meeting. Over three days, health care executives and quality professionals from pharmacies, health plans, health care providers, pharmacy benefit managers, life sciences companies, technology vendors, research institutions, academia and more addressed top issues and emerging trends in […] -
Focusing Quality Measures on Outcomes and Patient Experience
PQA is facilitating conversations to identify and elevate what patients, caregivers, and patient advocates might value and prioritize for future measurement. -
Frailty Index Scores as an Outcome for Deprescribing Initiatives: Bridging the Gap in Polypharmacy Quality Metrics
This guest blog is one in a series by sponsors of the 2026 PQA Annual Meeting explores polypharmacy quality metrics. PQA does not endorse, recommend or favor any product, service or organization that is a sponsor. Polypharmacy is broadly defined as the concurrent use of five or more medications. Although polypharmacy is common in the care […]
PQA In the News
-
Making Medication Management Services Measurable and Visible
-
PQA’s quality roadmap: Micah Cost on the next era of medication quality measurement
-
Focusing Quality Measures on Outcomes and Patient Experience
-
Value-Based Pharmacy Model Helps Boost Care Quality
-
PQA presents Quality Awards to 10 Medicare plan contracts for high achievement in medication quality measures
Request a PQA Expert
For members of the media or who wish to speak with an expert source on quality, please contact:
Download Media Materials
For PQA logos, images and other communications collateral, please contact:
Leading the Conversation About Medication Quality
“Quality medication use is essential to value-based, person-centered care. Through connection, collaboration, and consensus, PQA drives improvements to promote the best medication-related care and outcomes for patients.”
Micah Cost, PharmD, MS, CAE, Chief Executive Officer
Strategic Media Partnerships
PQA partners with a variety of media to provide news, insights and opinions.
Stay Informed
Get the latest PQA news and events delivered to your inbox.